Sy Mukherjee
Fortune
New York, NY, United States
Contact Sy
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
Recent articles by Sy:
Could Lowering Drug Prices Hamper Drug Innovation?—Brainstorm Health
© 2019 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy (Your California Privacy Rights). Fortune may receive compensation for some links to products and services on this website. Offers may be subject to change without notice. Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual… → Read More
California Wants to Prevent HIV By Making Treatments Prescription-Free
A new California law would allow pharmacies to sell HIV prevention drugs to people who don't have a prescription. → Read More
What We Should Consider on World Mental Health Day: Brainstorm Health
© 2019 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy (Your California Privacy Rights). Fortune may receive compensation for some links to products and services on this website. Offers may be subject to change without notice. Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual… → Read More
California Wants to Prevent HIV By Making Treatments Prescription-Free
A new California law would allow pharmacies to sell HIV prevention drugs to people who don't have a prescription. → Read More
This Startup Raised $3 Million to Staff Hospitals With Robots
Digital health firm Diligent Robotics has raised $3 million in a funding round for its robotic hospital assistant, Moxi. → Read More
How China Is Transforming the Biotech Industry: Brainstorm Health
Hello and happy Monday, readers. Fortune sat down with Brad Loncar, a biotech investor who specializes in cancer immunotherapy, at our offices last week. Loncar runs both a U.S.-based index fund for cancer drug companies and, more recently, launched another one focused on China. It was a fascinating conversation that covered everything from the U.S. […] → Read More
About Trump’s Executive Order on Medicare: Brainstorm Health
Good evening, readers. The Trump administration made a pretty significant move today on health care policy—President Trump issued an executive order on Medicare aiming to further privatize the public program, which covers some 60 million elderly and disabled Americans. To be clear, Medicare already contains a significant private component. More than 20 million beneficiaries (or […] → Read More
Meet the Man Who May Be the Next FDA Commissioner
Dr. Stephen Hahn, an oncologist and MD Anderson Cancer Center's chief medical executive, is reportedly Trump's pick to lead the FDA. → Read More
Let’s Chew on the Health Effects of Red Meat: Brainstorm Health
Good afternoon, readers. Let’s have a chat about meat. I’m usually hesitant to wade into nutritional debates—they are, often, driven by sensationalist claims, cherry-picked results, poorly designed studies, and a big old dollop of confirmation bias—but there’s a pretty big one dominating the internet right now. Specifically, a series of analyses published in the Annals […] → Read More
The Latest CRISPR Gene Editing Firm Preparing to Go Public: Brainstorm Health
Hello and happy Monday, readers! I hope you had a wonderful weekend. Last year, Feng Zhang, one of the pioneering minds behind CRISPR gene-editing technology, and a number of colleagues launched yet another startup in the space called Beam Therapeutics. Less than a year and a half later, the company is already plotting an IPO. […] → Read More
Big Tobacco 2.0: The Legal Fight Against Vaping Is Just Beginning
A three-pronged attack of federal regulation, state legal action, and class action lawsuits is coming for the makers of e-cigs. → Read More
'The Good Place' and What We Owe to Each Other in Health Care
The final season of NBC's "The Good Place" premiered last night. Here's what the show's moral philosophy could teach us about health care policy. → Read More
Peloton Goes Public—And Immediately Runs in Reverse
Digital health firm Peloton, which makes a newfangled, internet-connected exercise bike, went public and promptly saw its stock fall. → Read More
Juul's CEO Steps Down. But What Comes Next?
Juul CEO Kevin Burns is headed for the exits. A potential merger is in shambles (and probably dead). But what's next for the tobacco industry? → Read More
Fortune's Most Powerful Women in Health Care in 2019
Fortune's 2019 list of Most Powerful Women is out—and female leaders at Novartis, GSK, and numerous other firms made the cut. → Read More
How One Billionaire Is Trying to Fight Parkinson’s Through Competition: Brainstorm Health
Happy Monday, readers. I hope you had a wonderful weekend. This morning, Fortune published an exclusive first look into a joint effort by Ken Griffin, the billionaire founder and CEO of investment fund Citadel, and the Michael J. Fox Foundation (MJFF) to tackle Parkinson’s disease. You can read my full write-up of the $10 million […] → Read More
Citadel Billionaire Ken Griffin to Fund $10 Million Parkinson's Competition
Billionaire Citadel CEO Ken Griffin is funding a $10 million competition with the Michael J. Fox Foundation to create an important tool to fight Parkinson's disease. → Read More
About Congress’ New Drug Pricing Legislation: Brainstorm Health
Good afternoon, readers. Responding to widespread outrage, in the midst of an election season, lawmakers are proposing a whole bunch of initiatives to crack down on high prescription drug prices in America. The latest additions to the debate (none of which are necessarily expected to pass) include an earlier plan from Republican Sen. Chuck Grassley […] → Read More
Experts: The World Isn't Prepared for a Global Pandemic
A Global Preparedness Monitoring Board report in conjunction with the WHO finds 80 million people could be killed in a pandemic, and the world isn't ready. → Read More
A Pioneering Peanut Allergy Treatment on the Horizon: Brainstorm Health
FDA advisers overwhelmingly recommended approval of Aimmune's peanut allergy treatment. It could happen by January. → Read More